Literature DB >> 11283248

Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G/RGL.

Y Suzuki1, C Lanner, J H Kim, P G Vilardo, H Zhang, J Yang, L D Cooper, M Steele, A Kennedy, C B Bock, A Scrimgeour, J C Lawrence, A A DePaoli-Roach.   

Abstract

The regulatory-targeting subunit (RGL), also called GM) of the muscle-specific glycogen-associated protein phosphatase PP1G targets the enzyme to glycogen where it modulates the activity of glycogen-metabolizing enzymes. PP1G/RGL has been postulated to play a central role in epinephrine and insulin control of glycogen metabolism via phosphorylation of RGL. To investigate the function of the phosphatase, RGL knockout mice were generated. Animals lacking RGL show no obvious defects. The RGL protein is absent from the skeletal and cardiac muscle of null mutants and present at approximately 50% of the wild-type level in heterozygotes. Both the level and activity of C1 protein are also decreased by approximately 50% in the RGL-deficient mice. In skeletal muscle, the glycogen synthase (GS) activity ratio in the absence and presence of glucose-6-phosphate is reduced from 0.3 in the wild type to 0.1 in the null mutant RGL mice, whereas the phosphorylase activity ratio in the absence and presence of AMP is increased from 0.4 to 0.7. Glycogen accumulation is decreased by approximately 90%. Despite impaired glycogen accumulation in muscle, the animals remain normoglycemic. Glucose tolerance and insulin responsiveness are identical in wild-type and knockout mice, as are basal and insulin-stimulated glucose uptakes in skeletal muscle. Most importantly, insulin activated GS in both wild-type and RGL null mutant mice and stimulated a GS-specific protein phosphatase in both groups. These results demonstrate that RGL is genetically linked to glycogen metabolism, since its loss decreases PP1 and basal GS activities and glycogen accumulation. However, PP1G/RGL is not required for insulin activation of GS in skeletal muscle, and rather another GS-specific phosphatase appears to be involved.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11283248      PMCID: PMC86899          DOI: 10.1128/MCB.21.8.2683-2694.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

1.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

Authors:  G I Shulman; D L Rothman; T Jue; P Stein; R A DeFronzo; R G Shulman
Journal:  N Engl J Med       Date:  1990-01-25       Impact factor: 91.245

2.  Inactivation of nuclear inhibitory polypeptides of protein phosphatase-1 (NIPP-1) by protein kinase A.

Authors:  M Beullens; A Van Eynde; M Bollen; W Stalmans
Journal:  J Biol Chem       Date:  1993-06-25       Impact factor: 5.157

Review 3.  On target with a new mechanism for the regulation of protein phosphorylation.

Authors:  M J Hubbard; P Cohen
Journal:  Trends Biochem Sci       Date:  1993-05       Impact factor: 13.807

Review 4.  Serine/threonine protein phosphatases in the control of cell function.

Authors:  A A Depaoli-Roach; I K Park; V Cerovsky; C Csortos; S D Durbin; M J Kuntz; A Sitikov; P M Tang; A Verin; S Zolnierowicz
Journal:  Adv Enzyme Regul       Date:  1994

5.  Interaction of the ribosomal protein, L5, with protein phosphatase type 1.

Authors:  K Hirano; M Ito; D J Hartshorne
Journal:  J Biol Chem       Date:  1995-08-25       Impact factor: 5.157

6.  Effect of glucose phosphorylation on the activation by insulin of skeletal muscle glycogen synthase.

Authors:  C Villar-Palasi
Journal:  Biochim Biophys Acta       Date:  1995-05-11

7.  Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase.

Authors:  P R Shepherd; B T Navé; K Siddle
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

8.  Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin.

Authors:  D F Lazar; R J Wiese; M J Brady; C C Mastick; S B Waters; K Yamauchi; J E Pessin; P Cuatrecasas; A R Saltiel
Journal:  J Biol Chem       Date:  1995-09-01       Impact factor: 5.157

9.  Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.

Authors:  W Luo; I L Grupp; J Harrer; S Ponniah; G Grupp; J J Duffy; T Doetschman; E G Kranias
Journal:  Circ Res       Date:  1994-09       Impact factor: 17.367

10.  Amino acid sequence and expression of the hepatic glycogen-binding (GL)-subunit of protein phosphatase-1.

Authors:  M J Doherty; G Moorhead; N Morrice; P Cohen; P T Cohen
Journal:  FEBS Lett       Date:  1995-11-20       Impact factor: 4.124

View more
  64 in total

1.  Type 1 phosphatase, a negative regulator of cardiac function.

Authors:  Andrew N Carr; Albrecht G Schmidt; Yoichi Suzuki; Federica del Monte; Yoji Sato; Carita Lanner; Kristine Breeden; Shao-Ling Jing; Patrick B Allen; Paul Greengard; Atsuko Yatani; Brian D Hoit; Ingrid L Grupp; Roger J Hajjar; Anna A DePaoli-Roach; Evangelia G Kranias
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.

Authors:  Anna A DePaoli-Roach; Vincent S Tagliabracci; Dyann M Segvich; Catalina M Meyer; Jose M Irimia; Peter J Roach
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

3.  Tissue glycogen content and glucose intolerance.

Authors:  Masato Kasuga; Wataru Ogawa; Takeshi Ohara
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

4.  Multiple glycogen-binding sites in eukaryotic glycogen synthase are required for high catalytic efficiency toward glycogen.

Authors:  Sulochanadevi Baskaran; Vimbai M Chikwana; Christopher J Contreras; Keri D Davis; Wayne A Wilson; Anna A DePaoli-Roach; Peter J Roach; Thomas D Hurley
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

5.  Glycogen metabolism in tissues from a mouse model of Lafora disease.

Authors:  Wei Wang; Hannes Lohi; Alexander V Skurat; Anna A DePaoli-Roach; Berge A Minassian; Peter J Roach
Journal:  Arch Biochem Biophys       Date:  2006-11-03       Impact factor: 4.013

6.  Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases.

Authors:  Mitchell A Sullivan; Silvia Nitschke; Evan P Skwara; Peixiang Wang; Xiaochu Zhao; Xiao S Pan; Erin E Chown; Travis Wang; Ami M Perri; Jennifer P Y Lee; Francisco Vilaplana; Berge A Minassian; Felix Nitschke
Journal:  Cell Rep       Date:  2019-04-30       Impact factor: 9.423

7.  Novel method for detection of glycogen in cells.

Authors:  Alexander V Skurat; Dyann M Segvich; Anna A DePaoli-Roach; Peter J Roach
Journal:  Glycobiology       Date:  2017-05-01       Impact factor: 4.313

8.  Abnormal metabolism of glycogen phosphate as a cause for Lafora disease.

Authors:  Vincent S Tagliabracci; Jean Marie Girard; Dyann Segvich; Catalina Meyer; Julie Turnbull; Xiaochu Zhao; Berge A Minassian; Anna A Depaoli-Roach; Peter J Roach
Journal:  J Biol Chem       Date:  2008-10-13       Impact factor: 5.157

9.  A limited role for PI(3,4,5)P3 regulation in controlling skeletal muscle mass in response to resistance exercise.

Authors:  D Lee Hamilton; Andrew Philp; Matthew G MacKenzie; Keith Baar
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

10.  PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance.

Authors:  Sean M Crosson; Ahmir Khan; John Printen; Jeffrey E Pessin; Alan R Saltiel
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.